Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Driving with Type 1 Diabetes: Real-World Evidence to Support Starting Glucose Level and Frequency of Monitoring During Journeys

Steven Trawley, Amanda N Stephens, Sybil A McAuley, Jane Speight, Christel Hendrieckx, Sara Vogrin, Melissa H Lee, Barbora Paldus, Leon A Bach, Morton G Burt, Neale D Cohen, Peter G Colman, Elizabeth A Davis, D Jane Holmes-Walker, Alicia J Jenkins, Joey Kaye, Anthony C Keech, Kavita Kumareswaran, Richard J MacIsaac, Roland W McCallum, Catriona M Sims, Stephen N Stranks, Vijaya Sundararajan, Glenn M Ward, Timothy W Jones, David N O'Neal

(2022), DIABETES TECHNOL THE, 24(5), 350-356

DOI: 10.1089/dia.2021.0460

Hypertension in thyroid disease and primary hyperparathyroidism

Szwarcbard N Topliss DJ

(2022), In: Pappachan JM, Fernandez CJ (Editors) Endocrine Hypertension: From Basic Science to Clinical Practice Elsevier, New York, 249-261

Classification and laboratory diagnosis of diabetes mellitus

Hare MJL, Topliss DJ

(2022), In: Bandeira F, Gharib H, Griz L, Faria M (eds) Endocrinology and Diabetes – a problem oriented approach 2nd Edition Springer, New York,

A qualitative analysis of the needs and wishes of people with type 2 diabetes and healthcare professionals for optimal diabetes care

Silva C, Catapan S, Bird D, Clemensen J, Janda M, Fatehi F, Menon A , Russell A

(2022), DIABETIC MED, 39(9), e14886

DOI: 10.1111/dme.14886

Corneal dendritic cell dynamics are associate with clinical factors in Type 1 diabetes

Luisa H Colorado, Lauren Beecher, Nicola Prichard, Khaled Al Rashah, Cirous Dehghani, Anthony Russell, Rayaz A Malik, Nathan Efron, Katie Edward

(2022), J CLIN MED, 11(9), 2611

DOI: 10.3390/jcm11092611.

Thyroid hormone replacement therapy in hypothyroidism

Rosi L, Topliss DJ

(2022), Endocrinology Today, 11, 31-35

Finerenone in patients with chronic kidney disease and type 2 diabetes by sodium-glucose cotransporter 2 inhibitor treatment: the FIDELITY analysis

Rossing P, Anker SD, Filippatos G, Pitt B, Ruilope LM, Birkenfeld AL, McGill JB, Rosas SE, Joseph A, Gebel M, Roberts L, Scheerer MF, Bakris GL, Agarwal R; FIDELIO-DKD and FIGARO-DKD Investigators

(2022), DIABETES CARE, 45(12), 2991-8

DOI: 10.2337/dc22-0294

Letter to the Editor From Danek et al: "Environmental Pollution, Climate Change, and a Critical Role for the Endocrinologist"

Danek E, Blackburn D, Topliss DJ, Sztal-Mazer S

(2022), J CLIN ENDOCR METAB, 107(9), e3964

DOI: 10.1210/clinem/dgac351

Applying the TIRADS categorization for thyroid nodules in practice

Ng E, Topliss DJ

(2022), Endocrinology Today, 11, 32-5

Lenvatinib for the treatment of radioiodine-refractory differentiated thyroid cancer: treatment optimization for maximum clinical benefit

Wirth LJ, Durante C, Topliss DJ, Winquist E, Robenshtok E, Iwasaki H, Luster M, Elisei R, Leboulleux S, Tahara M

(2022), Oncologist, 27(7), 565-72

DOI: 10.1093/oncolo/oyac065

Q-122 as a novel non-hormonal oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blinded, placebo-controlled trial

Vrselja A, Latifi A, Baber RJ, Stuckey BGA, Walker MG, Stearns V, Hickey M, Davis SR

(2022), Lancet, 400(10364), 1704-11

DOI: 10.1016/S0140-6736(22)01977-8

Treating menopause - MHT and beyond

Davis SR, Baber R

(2022), NAT REV ENDOCRINOL, 18(8), 490-502

DOI: 10.1038/s41574-022-00685-4

Functional hypothalamic amenorrhoea, a diagnosis of exclusion

Ng E, Sztal-Mazer S, Davis SR

(2022), MED J AUSTRALIA, 216(2), 73-6

DOI: 10.5694/mja2.51376

Re: A system to detect unrecognised diabetes in a tertiary hospital

Ng E, Scholes G, Bach LA, Topliss DJ, Schneider HG, Sztal-Mazer S

(2022), Diabetic Med, 39(8), e14841

DOI: 10.1111/dme.14841

Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients

Burman P, Trouillas J, Losa M, McCormack,A, Petersenn S, Popovic V, Theodoropoulou M, Raverot G, Dekkers OM for the ESE survey collaborators

(2022), Eur J Endocrinol, 187(4), 593-605

DOI: 10.1530/EJE-22-0440

Adrenal gland haemorrhages following motor vehicle accident with resultant adrenal insufficiency

Szwarcbard N, Davis A, Bach LA, Hackman K

(2022), Endocrinology, diabetes & metabolism case reports, 2022(1), 21-0208

DOI: 10.1530/EDM-21-0208

Capillary ketone concentrations at the time of colonoscopy: A cross-sectional study with implications for SGLT2 inhibitor-treated type 2 diabetes (response to correspondence)

Hamblin PS, Wong R, Ekinci EI, Sztal-Mazer S, Balachandran S, Frydman A, Hanrahan TP, Hu R, Ket SN, Moss A, Ng M, Ragunathan S, Bach LA

(2022), Diabetes Care, 45(1), e17-18

DOI: 10.2337/dc21-0256

Diabetic ketoacidosis: a canary in the mine for mental health disorders?

Hamblin PS, Abdul-Wahab AL, Xu SFB, Steele CE, Vogrin S

(2022), Intern Med J, 52(6), 1002-8

DOI: 10.1111/imj.15214

Body mass index is inversely associated with capillary ketones at the time of colonoscopy: Implications for SGLT2i use

Hamblin PS, Wong R, Ekinci EI, Sztal-Mazer S, Balachandran S, Frydman A, Hanrahan TP, Hu R, Ket SN, Moss A, Ng M, Ragunathan S, Bach LA

(2022), Clin Endocrinol, 96(4), 549-57

DOI: 10.1111/cen.14621

Medical and Surgical Treatment of Thyroid Eye Disease

Hall AJ, Topliss DJ

(2022), Intern Med J, 52(1), 14-20

DOI: 10.1111/imj.15067

1 2 3